Paratek Pharmaceuticals Interest Expense 2011-2026 | PRTK

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Paratek Pharmaceuticals

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
18.1 M	17.4 M	20.2 M	16.4 M	11 M	5.08 M	3.22 M	770 K	718 K	-75 K	-159 K	9 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
20.2 M	-159 K	7.73 M

Quarterly Interest Expense Paratek Pharmaceuticals

2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
5.29 M	4.48 M	-	4.54 M	4.55 M	4.48 M	-	4.37 M	4.34 M	4.31 M	-	5.18 M	4.97 M	4.83 M	-3.88 M	4.56 M	3.99 M	3.23 M	-2.25 M	3.38 M	2.9 M	1.51 M	-1.02 M	1.41 M	1.13 M	1.13 M	-565 K	820 K	818 K	730 K	-737 K	47 K	25 K	-	-9.21 M	-158 K	-389 K	-280 K	-17 K	-17 K	-16 K	-25 K	-35 K	-45 K	-43 K	-36 K	-32 K	2 K	2 K	-29 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
5.29 M	-9.21 M	1.27 M

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	9 K	-	1052.0 %	$ 415 M	USA
Verastem VSTM	1.14 M	$ 5.04	-4.73 %	$ 349 M	USA
Voyager Therapeutics VYGR	1.65 M	$ 3.96	-4.12 %	$ 232 M	USA
VistaGen Therapeutics VTGN	5 K	$ 0.57	-5.87 %	$ 17.6 M	USA
AgeX Therapeutics AGE	51 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	29.5 M	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	-5.79 M	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	-1.72 M	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	4.67 M	-	-	$ 3.67 B	USA
I-Mab IMAB	722 K	-	-	$ 866 M	China
Genfit SA GNFT	4.68 M	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	3.69 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	48 K	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	737 K	-	-39.0 %	$ 4.57 M	USA
Arena Pharmaceuticals ARNA	4.16 M	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	2.67 M	-	-	$ 26.5 M	USA
Avenue Therapeutics ATXI	294 K	-	-52.27 %	$ 4.45 M	USA
Atreca BCEL	3 K	-	-11.76 %	$ 5.79 M	USA
Acorda Therapeutics ACOR	31.5 M	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	16.4 M	-	-	$ 546 M	USA
Avid Bioservices CDMO	4.34 M	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	8.23 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	432 K	-	2.71 %	$ 14 M	USA
Advaxis ADXS	28 K	-	-9.65 %	$ 45.9 M	USA
Adaptive Biotechnologies Corporation ADPT	11.8 M	$ 12.41	-11.1 %	$ 1.88 B	USA
Wave Life Sciences Ltd. WVE	527 K	$ 6.37	2.66 %	$ 1.07 B	Singapore
Xenetic Biosciences XBIO	5.72 K	$ 2.72	-2.86 %	$ 4.63 M	USA
XBiotech XBIT	1.46 M	$ 2.27	-1.73 %	$ 69.2 M	USA
Xenon Pharmaceuticals XENE	484 K	$ 54.48	-1.89 %	$ 4.24 B	Canada
Xeris Pharmaceuticals XERS	-24.3 M	$ 5.4	-3.05 %	$ 866 M	USA
X4 Pharmaceuticals XFOR	-753 K	$ 4.04	-6.26 %	$ 171 M	USA
Xencor XNCR	-73 K	$ 11.42	-7.23 %	$ 848 M	USA
XOMA Corporation XOMA	12.2 M	$ 30.17	-1.18 %	$ 364 M	USA
BeiGene, Ltd. BGNE	-42.6 M	-	0.49 %	$ 251 B	Cayman-islands
22nd Century Group XXII	-207 K	$ 2.41	-18.03 %	$ 444 K	USA
BioDelivery Sciences International BDSI	-6 K	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	3.59 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	2.7 M	-	-	$ 3.74 B	USA
Zai Lab Limited ZLAB	3.54 M	$ 18.0	2.8 %	$ 19.7 B	China
Enlivex Therapeutics Ltd. ENLV	874 K	$ 1.05	-3.67 %	$ 21.5 M	Israel
Enochian Biosciences ENOB	122 K	-	-	$ 40.5 M	USA